Business

Enveric Biosciences to Participate in a Panel Discussion at Needham’s Virtual Psychedelics Forum

CAMBRIDGE, Mass., April 21, 2026--Enveric Biosciences (NASDAQ: ENVB) ("Enveric" or the "Company"), a biotechnology company advancing novel neuroplastogenic small-molecule therapeutics to address psychiatric and neurological disorders, today announced that Director and CEO, Joseph Tucker, Ph.D., will participate in a panel discussion at Needham’s upcoming Virtual Psychedelics Forum. The panel, "Beyond TRD (Treatment-Resistant Depression): Non-Hallucinogens and New Indications," is scheduled for M

articleEnveric Biosciences, Inc.April 21, 20263/company/enveric-biosciences-inc/news/enveric-biosciences-to-participate-in-a-panel-discussion-at-needhams-virtual-psychedelics-forum
Enveric Biosciences to Participate in a Panel Discussion at Needham’s Virtual Psychedelics Forum

About this update from Enveric Biosciences, Inc.

[{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":1024,"height":512,"url":"https://media.zenfs.com/en/business-wire.com/41e27f2004776c05472973cf8e3719df"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/MuSQj6px.5J434G2zaA2TQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTQ4MA--/https://media.zenfs.com/en/business-wire.com/41e27f2004776c05472973cf8e3719df","width":960,"height":480},"lightbox":{"url":"https://s.yimg.com/ny/api/res/1.2/v1m.AX3w_0nxJIGppVg7sg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTIwNDg7aD0xMDI0/https://media.zenfs.com/en/business-wire.com/41e27f2004776c05472973cf8e3719df","width":1024,"height":512}},"lazy":false},{"type":"text","content":"CAMBRIDGE, Mass., April 21, 2026--(BUSINESS WIRE)--Enveric Biosciences (NASDAQ: ENVB) ("Enveric" or the "Company"), a biotechnology company advancing novel neuroplastogenic small-molecule therapeutics to address psychiatric and neurological disorders, today announced that Director and CEO, Joseph Tucker, Ph.D., will participate in a panel discussion at Needham’s upcoming Virtual Psychedelics Forum. The panel, "Beyond TRD (Treatment-Resistant Depression): Non-Hallucinogens and New Indications," is scheduled for Monday, April 27, 1:00 PM - 2:00 PM ET.","length":585,"tagName":"p"},{"type":"text","content":"Event Details:","length":14,"tagName":"p"},{"type":"table","headerItems":[],"items":[{"val":[{"colspan":"1","rowspan":"1","style":"vertical-align:top;border-top:solid black 1.0pt;border-bottom:solid black 1.0pt;border-left:solid black 1.0pt;border-right:solid black 1.0pt;width:15%;padding-left:5.0px;","val":[{"type":"text","content":"Event:","length":6,"tagName":"p","attribs":{}}]},{"colspan":"1","rowspan":"1","style":"vertical-align:top;border-top:solid black 1.0pt;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;width:85%;padding-left:5.0px;","val":[{"type":"text","content":"Needham’s Virtual Psychedelics Forum","length":36,"tagName":"p","attribs":{}}]}]},{"val":[{"colspan":"1","rowspan":"1","style":"vertical-align:top;border-bottom:solid black 1.0pt;border-left:solid black 1.0pt;border-right:solid black 1.0pt;width:15%;padding-left:5.0px;","val":[{"type":"text","content":"Topic:","length":6,"tagName":"p","attribs":{}}]},{"colspan":"1","rowspan":"1","style":"vertical-align:t...

More updates from Enveric Biosciences, Inc.

Enveric BiosciencesTreatment-Resistant DepressionForward-Looking Statementsbiotechnology companypanel discussionneurological disordersNon-HallucinogensJoseph Tucker